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Abstract 
 
The glutamatergic mGlu5 receptor and the purinergic P2Y12 receptor are two 
important targets in the development of novel treatments of gastroesophageal 
reflux disease (GERD) and thrombosis, respectively. 
   Synthesis was developed to investigate the structure-activity relationships (SAR) 
of a novel series of 2-alkynylpyridine derivatives as mGluR5 antagonists. This led 
to the discovery of antagonists with potency in the low-nanomolar range. High 
microsomal metabolism, possibly due to high lipophilicity, remained an issue.  
   Further, SAR development for a series of ethyl 6-piperazinylnicotinates, featured 
by a urea linker, as antagonists of the P2Y12 receptor showed the 3-
ethoxycarbonyl substituent as central to binding. The low aqueous solubility was 
addressed by variation of the linker which led to the discovery of sulfonylureas as 
P2Y12 antagonists. The chemical stability of the sulfonylurea compounds during 
prolonged storage in solution was found to be related to the sulfonyl urea linker 
and depended on the type of solvent and the substitution pattern of the sulfonyl 
urea functionality. 
   Synthesis was developed to facilitate the replacement of the 2-methyl substituent 
on pyridine with more electron donating substituents and of the 3-ethoxycarbonyl 
substituent with 5-ethyl-oxazoles. Both strategies led to compounds with higher 
metabolic stability, but also with lower potency. 
   Pair-wise comparison of compounds showed that a correctly positioned alkyl 
group, like in an ethyl ester or a 5-ethyl-oxazole, and a correctly positioned strong 
hydrogen bond acceptor both were required for binding. 
   Chemical design was used to study how the regioselectivity Rsel for the 2-
position depended on the character of the 3-substituent in the reaction of 3-
substituted 2,6-dichloropyridines with 1-methylpiperazine. It was found that Rsel 
depended on neither of the parameters PI, MR, or σp, but showed a statistically 
significant correlation with the Verloop steric parameter B1 (R2: 0.45, p = 0.006). 
This implied that 3-substituents that are bulky close to the pyridine ring directed 
the regioselectivity towards the 6-position. With R3 = -CO2CH3 a study of the 
solvent effect showed that Rsel could be predicted by the Kamlet-Taft equation: 
Rsel = 1.28990 + 0.03992α - 0.59417β - 0.46169π* (R2 = 0.95; p = 1.9 x 10-10). 
The dependency on the solvatochromic β parameter meant that the 16:1 
regioselectivity for the 2-isomer in DCM (β = 0.10) could be switched to a 2:1 
selectivity for the 6-isomer in DMSO (β = 0.76). 
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